Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Related Post

Redenlab at the 39th Annual HDSA – May 30 – June 1

  • Posted on 30 May, 2024
    Join Redenlab at the upcoming Huntington’s Disease Society of America (HDSA) National Convention, starting on the 30th of May 2024...
    Read more

    2023 Digital Health Innovation in Clinical Trials, Drug Development and Mobile Healthcare: June 6 – 7, 2023

    • Posted on 4 March, 2023
      Join World BI for its 23rd rebranded edition of the Digital Health Innovation in Clinical Trials, Drug Development and Mobile...
      Read more

      2022 Kabuki Syndrome Foundation Virtual Conference: October 26 – 27, 2022

      • Posted on 17 November, 2022
        The 4th Annual Kabuki Syndrome Foundation Research Conference to be held virtually on Friday, November 4, 2022. The Annual Conference...
        Read more